
Healthcare · BSE
Star Imaging and Path Lab Limited, founded in 2004, is a healthcare company offering a wide range of diagnostic services, including radiology tests like X-rays, CT scans, MRIs, and ultrasounds, as well as pathology services such as blood tests, microbiology, PCR, and histopathology. With advanced equipment and skilled medical professionals, the company focuses on delivering accurate and timely results to support effective diagnosis and treatment. Operating across multiple regions, it serves both individual patients and healthcare institutions. As of September 30, 2024, the company employs 209 full-time staff, including executive directors.
Price Band
₹135 – ₹142
Issue Size
₹69.46 Cr
Lot Size
1000 shares
GMP
+3.5%
Est. Listing
₹147
at current GMP
Subscribed
5.67x
overall
Open
8 Aug 2025
Close
12 Aug 2025
Allotment
13 Aug 2025
Refund
14 Aug 2025
Demat Credit
15 Aug 2025
Listing
18 Aug 2025
Last updated: 19 Oct 2026
Current Premium
Issue Price (Upper)
₹142
Band: ₹135 – ₹142
Estimated Listing Price
₹147
Upper price + GMP
Lot Size
1000 shares
Min investment ₹1,42,000
Estimated Profit / Lot
₹5,000
1000 × ₹5
Grey Market Premium trend
+₹5
▲ 0 today
Updated less than a minute ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | +₹5 | 3.5% | ₹147 |
| 30 Oct 2026 | +₹5 | 3.5% | ₹147 |
| 29 Oct 2026 | +₹5 | 3.2% | ₹147 |
GMP is unofficial market data. Not a guarantee of listing performance.
Star Imaging and Path Lab Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹69.46 Crores. The shares are offered at a price band of ₹135 to ₹142 per equity share on BSE. Currently, grey market participants and retail investors are watching the bidding trend, premium movement, and anchor book demand with keen interest.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 1000 shares (approx. ₹1,42,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Kfin Technologies Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2025-08-15, while un-allotted funds or UPI block mandates will be released on 2025-08-14.
The latest grey market premium for Star Imaging and Path Lab Limited IPO is ₹5, which indicates an expected listing price of ₹147.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.